Bio-Techne
TECH
#1482
Rank
HK$90.00 B
Marketcap
HK$566.46
Share price
-0.32%
Change (1 day)
-7.23%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Net assets

Net assets on the balance sheet as of September 2024 : HK$16.59 Billion

According to Bio-Techne's latest financial reports the company has HK$16.59 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Bio-Techne - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$HK$15.41 B15.5%
2022-06-30$HK$13.34 B9.41%
2021-06-30$HK$12.19 B13.95%
2020-06-30$HK$10.70 B17.54%
2019-06-30$HK$9.10 B7.54%
2018-06-30$HK$8.46 B14.27%
2017-06-30$HK$7.41 B8.63%
2016-06-30$HK$6.82 B3.91%
2015-06-30$HK$6.56 B6.51%
2014-06-30$HK$6.16 B7.75%
2013-06-30$HK$5.72 B9.34%
2012-06-30$HK$5.23 B14.71%
2011-06-30$HK$4.56 B16.72%
2010-06-30$HK$3.90 B10.47%
2009-06-30$HK$3.53 B-6.85%
2008-06-30$HK$3.79 B11.03%
2007-06-30$HK$3.42 B29.47%
2006-06-30$HK$2.64 B26.94%
2005-06-30$HK$2.08 B-10.26%
2004-06-30$HK$2.31 B25.7%
2003-06-30$HK$1.84 B14.54%
2002-06-30$HK$1.61 B16.23%
2001-06-30$HK$1.38 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
HK$381.09 B 2,195.79%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$58.11 B 250.12%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$200.94 B 1,110.53%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$398.21 B 2,298.94%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.39 B 65.06%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
HK$148.27 B 793.23%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.36 B-97.77%๐Ÿ‡บ๐Ÿ‡ธ USA